| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Mar―26 |
Aflibercept plus FOLFIRI as second-line therapy in metastatic colorectal cancer (mCRC) during pandemic COVID-19: a real-world experience |
R. De Luca, P. Vitale, A. Galvano, G. Rosati, I. Di Giovanni, A. Grassedonia, et al. (+3) G. Lo Re, R. Addeo, G. Cicero |
| 2 |
[GO] |
2023―Sep―21 |
Surgical Oncology before and during COVID-19 pandemic: an assessment through the data of the National Outcomes Evaluation Program - PNE |
E. Eugeni, B. Giordani, M. Cuomo, G. Duranti, E. Guglielmi, G. Baglio |
| 3 |
[GO] |
2022―Mar―03 |
ACCESS TO EARLY PHASE CLINICAL TRIALS AT THE TIME OF THE COVID-19 PANDEMIC: AN ITALIAN SURVEY |
P. Lombardi, R. Falcone, M. Filetti, V. Altamura, R. Giusti, F. Paroni Sterbini, et al. (+4) A. Pietragalla, S. Duranti, G. Scambia, G. Daniele |
| 4 |
[GO] |
2022―Jan―08 |
THE IMPACT OF COVID-19 ON NEW CANCER DIAGNOSES |
L. Mangone, P. Giorgi Rossi Giorgi Rossi, I. Bisceglia, R. Grilli, C. Pinto |
| 5 |
[GO] |
2022―Jan―08 |
THROUGH AND BEYOND COVID-19 PANDEMIC: A NEW SCENARIO FOR CARDIONCOLOGY |
L. Tarantini, A. Camerini, M.L. Canale, I. Bisceglia, D. Gabrielli, F. Colvicchi, et al. (+2) M. M. Gulizia, A. Navazio |
| 6 |
[GO] |
2022―Jan―08 |
CLINICAL RESEARCH DURING COVID-19 SPREAD:MANAGING AN EMERGENCY WITHIN A PANDEMIC OUTBREAK |
C. Cagnazzo, S. Testoni, R. Cenna, S. Stabile, S. Stabile, E. Tirtei, et al. (+2) N. Bertorello, F. Fagioli |
| 7 |
[GO] |
2022―Jan―08 |
A serious challenge in fighting the COVID 19 pandemic: SARS CoV 2 vaccines in oncologic patients |
M. Ruella, G. Ghilardi |
| 8 |
[GO] |
2021―Dec―17 |
COVID-19 outbreak in Italy. Report of 20 cancer patients with COVID-19 treated at home during the first wave |
L. Cavanna, S. Casali, C. Citterio, G. Gianlupi, L. Pilla |
| 9 |
[GO] |
2021―Dec―17 |
COVID-19 still on center stage in Oncology debates |
A. Giordano, C. Pinto, F. Pentimalli |
| 10 |
[GO] |
2021―Dec―17 |
SARS-CoV-2 and oncology |
L. Fratino, D. Serraino |
| 11 |
[GO] |
2021―Dec―17 |
PULMONARY CAPILLARY HEMANGIOMATOSIS INDUCED BY SARS-COV-2 INFECTION. A CASE REPORT |
D. Fanni, R. Demontis, L. Saba, D. Barcellona, N. Lenigno, C. Gerosa, et al. (+5) C. Botta, F. Cau, G. Faa, R. Sciot, E. D’Aloia |
| 12 |
[GO] |
2021―Dec―15 |
THE RESILIENCE OF ONCOLOGISTS DURING THE EARLY TIME OF THE COVID-19 PANDEMIC |
A. Lasagna, S. Secondino, F. Agustoni, T. Monaco, I. Imarisio, A. Pagani, et al. (+9) G. Rizzo, R. J. Tancredi, E. Pozzi, E. Ferraris, S. Chiellino, C. Gandini, A. Ferrari, S. G. Brugnatelli, P. Pedrazzoli |
|
